General Information
Version
4 (replaces version 3
Revision date
2019-01-30
Product name
Sirolimus
Chemical name
(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)- 9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-9,27-dihydroxy-3-[(1R)-2-[(1S,3R,4R)-4-hydroxy-3- methoxycyclohexyl]-1-methylethyl]-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-23,27-epoxy-3H-pyrido[2,1-c][1,4]-
CAS No.
53123-88-9
REACH No
01-2120055479-46-XXXX
Emergency telephone
+34961869090
Icons in SDS
Company Information
company name
GUINAMA S.L
e-mail address of the competent person responsible for the Safety Data Sheet
ventas@guinama.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H351, H361, H372
Hazard statements
Code
Statements
H351
Suspected of causing cancer
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
In accordance with
2.2 Label elements
Labelling in accordance with
Signal word
Danger
Hazard statements
H351 Suspected of causing cancer. H361 Suspected of damaging fertility or the unborn child. H372 Causes damage to organs through prolonged or repeated exposure.
Precautionary statements
P201 Obtain special instructions before use. P202 Do not handle until all safety precautions have been read and understood. P260 Do not breathe dust/fume/gas/mist/vapours/spray. P264 Wash ... thoroughly after handling. P270 Do not eat, drink or smoke when using this product. P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/… P308+P313 IF exposed or concerned: Get medical advice/attention. P314 Get medical advice/attention if you feel unwell. P405 Store locked up. P501 Dispose of contents/container in accordance with current laws
2.3 Other hazards
The substance is not PBT The substance is not vPvB Substance does not have endocrine disrupting properties. In normal use conditions and in its original form, the product itself does not involve any other risk for health and the environment.
